Progress in Medicinal Chemistry [Hardcover]

Progress in Medicinal Chemistry provides a review of eclectic developments in medicinal chemistry. This volume continues in the serial's tradition of providing an insight into the skills required of the modern medicinal chemist; in particular, the use of an appropriate selection of the wide range of tools now available to solve key scientific problems.

• Presents the latest research in the field of drug discovery
• Publishes on a twice yearly basis to bring you the most innovative updates in medicinal chemistry
• Available as an online resource via ScienceDirect

1. Designing drugs to avoid toxicity - Graham F Smith
2. Prostaglandin D2 receptor CRTH2 Antagonists for the treatment of inflammatory diseases - Jeffrey Chen & Alison Budelsky
3. Progress in the Development of Small Molecule Therapeutics That Target Th17 Cell Function for the Treatment of Immune-Inflammatory Diseases - Stephen Shuttleworth, Paul Townsend, Franck Silva, Alexander Cecil, Thomas Hill, Cyrille Tomassi, Helen Rogers and Rebecca Harrison
4. Therapeutic Applications Of Iminosugars: Current Perspectives And Future Opportunities - Graeme Horne & Francis X. Wilson

The latest in the series with a focus on biochemical targets and pharmacokinetics

Dr Geoff Lawton has extensive experience in new medicine discovery across many therapeutic areas in both large and small companies and is a co-inventor of a marketed drug (Cilazapril). He is a former Director of Chemistry at Roche UK, and Vice-president Chemistry and Preclinical Sciences within Roche Bioscience, Palo Alto, USA. He was for five years the research member of a global therapy area strategy planning team for inflammatory diseases, aligning research with the clinical developmelC;